Case Reports
Journal Article
Add like
Add dislike
Add to saved papers

Safe Simultaneous Use of Sacral Neuromodulation and Vagal Nerve Stimulation.

INTRODUCTION: The potential for costimulation with competitive effects between implanted electronic devices remains speculative both at the level at the implanted device and with active programming but also at the retrograde site of action. We present a patient with an implanted vagal nerve stimulator for refractory epilepsy who underwent successful staged sacral neuromodulation (SNS) and benefits from both technologies.

CASE: This is a case report of a 42-year-old female patient with a history notable for medically intractable epilepsy, temporal lobectomy, and vagal nerve stimulation who subsequently underwent staged SNS for refractory overactive bladder syndrome. The patient continues to benefit from sustained reduction in her bladder issues and without dimunition of her seizure threshold at 6-month follow-up.

DISCUSSION: Different action sites for SNS as well as vagal nerve stimulation are possible. The role of the thalamus in continence and seizure activity is reviewed. There does not seem to be an interactive effect during the simultaneous use of these 2 modalities.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app